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a b s t r a c t
Schizophrenia is associated with premature mortality and a high rate of sudden, unexpected deaths. Autopsy
data are scant, and in studies using death certiﬁcates or root cause assessments, a majority of sudden deaths
remained unexplained. In the community, post-mortem data indicate that the most common cause of sudden
“natural” death is coronary artery disease. In this study, we used autopsy ﬁndings to determine the cause of
sudden death in a consecutive cohort of 7189 schizophrenia patients admitted to a free-standing, psychiatric
teaching hospital from 1989 to 2013. Medical record review identiﬁed 57 patients (0.79%) who died suddenly
and unexpectedly during hospitalization. Autopsies were performed in 51 (89.5%) patients (55.9 ± 9.4 years,
male = 56.9%). Autopsy-based causes of sudden death were most commonly cardiovascular disorders (62.8%).
Speciﬁc causes included myocardial infarction (52.9%), pneumonia (11.8%), airway obstruction (7.8%), myocarditis (5.9%), and dilated cardiomyopathy, hemopericardium, pulmonary embolus, hemorrhagic stroke and
brain tumor (2.0% each). The sudden death remained unexplained in 6 (11.8%) patients, 3 of whom had evidence
of coronary arteriosclerosis on autopsy. Patients with and without myocardial infarction were similar regarding
age, gender, smoking, body mass index and psychotropic treatment (p values ≥ 0.10). In conclusion, sudden
cardiac death occurs at a 0.8% rate in a psychiatric hospital, well above general population rates. Autopsy ﬁndings
indicate that sudden death in schizophrenia is caused by structural cardiovascular, respiratory and neurological
abnormalities, with most cases due to acute myocardial infarction. Early recognition and treatment of coronary
artery disease must become a clinical priority for all adults with schizophrenia.
© 2014 Elsevier B.V. All rights reserved.

1. Introduction
The physical health of patients with schizophrenia is poor (De Hert
et al., 2011a) and a large body of evidence has documented their
shortened life expectancy (Osby et al., 2000; Rasanen et al., 2005;
Colton and Manderscheid, 2006; Bushe et al., 2010). Suicides, accidents
and cardiovascular disorders are considered the main reasons for the
excess of premature, sudden and unexpected deaths in this population
(Ruschena et al., 1998; Appleby et al., 2000; Colton and Manderscheid,
2006; Loas et al., 2008; Bushe et al., 2010; Manu et al., 2011). In patients
treated with antipsychotic drugs, which include a large number of
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individuals receiving psychiatric care for schizophrenia, sudden cardiac
death has been the focus of large epidemiological studies in the United
States (Ray et al., 2001; Ray et al., 2009). Using death certiﬁcates and
complex algorithms to exclude patients who died from previously
known noncardiac conditions and to adjust for co-morbid somatic
disorders, the investigators established that the incidence-rate ratio of
sudden cardiac death was doubled in individuals prescribed ﬁrst- or
second-generation antipsychotics in the last month of life (Ray et al.,
2009). The ﬁndings were thought to reﬂect the dose-dependent
antipsychotic drugs' inhibitory effect on phase 3 of the myocardial cell
repolarization, which may lead to torsades de pointes, an arrhythmia
that may lead to ventricular ﬁbrillation and sudden death. However,
the ﬁndings were disputed by the American Psychiatric Association's
Council on Research, which has stated that “a retrospective analysis of
death certiﬁcates to evaluate mortality by SCD [sudden cardiac death],
… may overestimate SCD incidence” (Lieberman et al., 2012). The
American Psychiatric Association's position is supported by the
methodology used to ascertain the sudden arrhythmic death syndrome

http://dx.doi.org/10.1016/j.schres.2014.03.011
0920-9964/© 2014 Elsevier B.V. All rights reserved.

Downloaded from ClinicalKey.com at Hofstra North Shore-LIJ School of Medicine North Shore-LIJ Health System February 01, 2017.
For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.

P. Ifteni et al. / Schizophrenia Research 155 (2014) 72–76

(Behr et al., 2007). This diagnosis is made in cases of sudden death with
no history of cardiac disease, no identiﬁable macroscopic cause of death
at a complete autopsy, and no abnormal ﬁndings on microscopic examination of the heart by a cardiac pathologist.
Autopsy ﬁndings in patients with schizophrenia who died suddenly
have been reported only a few times in the past two decades. In a study
of 66 cases presented to the medical examiner in Maryland from 1994
through 1996, the majority of deaths not due to accidents or suicides
were caused by atherosclerotic heart disease (Chute et al., 1999). In a
10-year review of 683 autopsies performed in people with a history of
schizophrenia by the Department of Forensic Medicine in Sydney,
Australia, the main cause of natural death was cardiovascular disease,
present in 23% of a cohort in which 37% of deaths were attributed
to suicide or voluntary overdose with prescribed or illicit drugs
(Sweeting et al., 2013). In this Australian series, 72 (11%) of cases
remained unexplained, and 30 of these patients were presumed to have
primary arrhythmogenic disorders which may have been discoverable
at a “molecular autopsy” (Semsarian and Hamilton, 2012). A study limited to 10 cases of clozapine-induced myocarditis diagnosed at autopsy
included 3 patients with sudden and unexpected death (Ronaldson
et al., 2011). The signiﬁcance of these observations is limited by selection
bias and incomplete clinical data.
Reported rates of sudden cardiac death in the general population
range from 0.1 to 0.2% (Zipes and Wellens, 1998). In contrast with the
limited data regarding the etiology of sudden death in patients with
schizophrenia, autopsies have established that the majority of sudden
and unexpected fatalities in the community are due to coronary artery
disease. In a prospective study involving 692 individuals without history
of cardiac disease autopsied in 83 coroner's jurisdictions in England,
death was ascribed to coronary artery disease in 82.4% of cases, with
acute ischemic changes in more than half of the subjects (Bowker
et al., 2003). The proportion of coronary artery disease as the cause of
sudden death was 63% in Ireland (Downes et al., 2010), and 80% in
Hennepin County, Minnesota (Adabag et al., 2010). Similar ﬁndings
have been reported in autopsies of adult hospital patients in Pittsburgh,
Pennsylvania, who were presumed to have died of cardiac arrhythmia,
but of whom 62% had N75% coronary artery stenosis and 53% had
histological evidence of myocardial infarction (Nichols and Chew,
2012).
In this study, we present analyses of a consecutive cohort of patients
treated for schizophrenia who died suddenly and unexpectedly in
Romania, a country in which the public health legislation mandates
autopsies for all patients dying during a hospital stay. We adopted a
null hypothesis and postulated that the main cause of death in patients
with schizophrenia is no different than in the general population, i.e.,
coronary artery disease with evidence of acute myocardial infarction.
2. Materials and methods
2.1. Setting
The patients described in this report were admitted to a 120-bed,
free standing, public psychiatric hospital located in Brasov, Romania
(population 277,000). The clinical care is provided by board certiﬁed
psychiatrists afﬁliated with the local medical school. Patients deemed
by their treating psychiatrist to have a signiﬁcant medical deterioration
are transferred the same day to the county hospital. The retrospective
review of medical records was approved by the hospital's Ethics in
Research Committee.
2.2. Patient population
From January 1, 1989 through December 31, 2011, the hospital
admitted 7189 adult patients diagnosed with schizophrenia according
to the contemporaneous version of the Diagnostic and Statistical Manual
of the American Psychiatric Association. Public health legislation
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requires a forensic evaluation of all inpatient deaths. The post-mortem
examinations are carried out by board certiﬁed pathologists employed
by the government at the local Institute for Legal Medicine. Autopsies
are performed in all cases and the pathology report must include a
summary of the ﬁndings. Exceptions from autopsy are granted only
for narrowly deﬁned religious or personal preference reasons.
2.3. Deﬁnition of sudden death
Hospital records over the 25-year period of the study identiﬁed 57
patients who died suddenly and unexpectedly. All of these patients
died while being asymptomatic or within 1 h of new symptom(s)
onset. None of these patients died of physical trauma, homicide, suicide
or accidental drug overdose.
2.4. Data collection
Autopsies were performed in 51 (89.5%) of the 57 patients with
schizophrenia who died suddenly and unexpectedly. Data extracted
from their medical records and the post-mortem examination report
included demographic information, duration of psychiatric disorder,
length of stay prior to death, past medical history, medication regimen
at the time of death, and autopsy ﬁndings. The chlorpromazine equivalent of the antipsychotic drugs received in 24 h preceding the sudden
death was calculated according to published guidelines (American
Psychiatric Association, 1997; Woods, 2003) and as previously used
(Correll et al., 2009).
2.5. Statistical analyses
The autopsy ﬁndings were used to divide the sample into two
groups of patients with or without myocardial infarction at autopsy.
The signiﬁcance of the differences between groups was assessed with
χ2 or Fisher's Exact tests for proportions and t test for continuous
variables. All data were analyzed with JMP 5.0.1, 1989–2003, SAS
Institute, Inc, Cary, North Carolina. All tests were two-sided, and alpha
was set at b 0.05.
3. Results
The study group comprised 29 males (56.9%) and 22 females (43.1%)
with a mean age of 55.9 ± 9.4 years (Table 1). Patients had been
diagnosed with schizophrenia for an average of 27.7 ± 10.3 years
prior to their sudden death. The admitting diagnosis for the last hospitalization was paranoid subtype in 47 patients (92.2%), and catatonic
and undifferentiated in 2 patients (3.9%) each. With the exception of
one patient with pneumonia in whom the antipsychotic was stopped
2 days prior to death, all patients had received antipsychotic drugs in
24 h preceding their death, which had occurred after an average length
of stay of 11.7 ± 7.6 days. The past medical history, as recorded by the
admitting psychiatrists, was remarkable for congestive heart failure (4
patients, 7.8%), arterial hypertension (4 patients, 7.8%), bronchial
asthma or chronic obstructive pulmonary disease (3 patients, 5.9%),
diabetes mellitus (1 patient, 2.0%) and dyslipidemia (1 patient).
3.1. Causes of death
Cardiovascular disorders, identiﬁed in 32 (62.8%) of the cases, were
the most common cause of sudden death in this cohort of inpatients
with schizophrenia. The cardiovascular disorders included 27 patients
(52.9%) with acute myocardial infarction, and 3 patients (5.9%) with
myocarditis. None of the cases of myocarditis had been treated with
clozapine. One patient (2.0%) had dilated cardiomyopathy and acutely
decompensated heart failure with pulmonary edema. The cause of
death was identiﬁed in one patient (2%) as cardiac tamponade due to
hemopericardium. This patient was the only one restrained just before
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Table 1
Demographic features and psychotropic drug treatment of schizophrenia inpatients who died suddenly and unexpectedly and had a post-mortem examination.
Characteristic

Total (N = 51)

Myocardial infarction on autopsy (N = 27)

No myocardial infarction on autopsy (N = 24)

p

Age (years ± S.D.)
Male gender, N (%)
Duration of schizophrenia (years ± S.D.)
Length of stay (days ± S.D.)
Antipsychotic drugs at the time of death, N (%)
First generation antipsychotics
Haloperidol
Levopromazine
Chlorpromazine
Thioproperazine
Second generation antipsychotics (%)
Clozapine
Amisulpride
Olanzapine
Quetiapine
Number of antipsychotic drugs ± S.D.
Antipsychotic polytherapy, N (%)
Chlorpromazine equivalent (mg/day ± S.D.)
Other psychotropics at the time of death, N (%)
Benzodiazepines
Mood stabilizers
Antidepressants

55.9 ± 9.4
29 (56.9%)
27.7 ± 10.3
11.7 ± 7.6

53.9 ± 9.0
16 (59.3%)
25.6 ± 10.0
10.5 ± 7.0

58.3 ± 9.9
13 (54.2%)
30.1 ± 10.5
13.0 ± 8.2

0.10
0.71
0.13
0.26

43 (83.4%)
38 (74.5%)
19 (37.3%)
5 (9.8%)
2 (3.9%)
8 (15.7%)
3 (5.9%)
3 (5.9%)
1 (2.0%)
1 (2.0%)
1.43 ± 0.58
20 (39.2%)
420.1 ± 187.1

23 (85.4%)
19 (70.4%)
9 (33.3%)
4 (14.8%)
2 (7.4%)
4 (14.8%)
1 (3.7%)
2 (7.4%)
1 (3.7%)
0 (0.0%)
1.41 ± 0.64
9 (33.3%)
410.2 ± 198.3

20 (83.3%)
20 (83.3%)
10 (41.7%)
1 (4.2%)
0
4 (16.7%)
2 (8.3%)
1 (4.2%)
0 (0.0%)
1 (4.2%)
1.46 ± 0.51
11 (45.8%)
431.3 ± 173.6

0.85
0.28
0.54
0.20
0.17
0.85
0.48
0.62
0.25
0.28
0.76
0.36
0.69

38 (74.5%)
18 (35.3%)
2 (3.9%)

19 (70.4%)
12 (44.4%)
0 (0.0%)

19 (79.2%)
6 (25%)
2 (8.3%)

0.47
0.15
0.13

the sudden death. He had a ruptured left ventricular wall, and may have
had an early myocardial infarction, but the report of microscopic ﬁndings could not be located for this retrospective analysis.
Among the 11 (21.6%) patients who died of a respiratory disorder, 6
(11.8%) had pneumonic consolidations, 4 (7.8%) had airway obstruction
(laryngeal or tracheal) with food boluses, and one (2.0%) died of a
massive pulmonary embolus. In two cases (3.9%), the death was due
to a neurological disorder, a hemorrhagic stroke and a brain tumor
(Table 2).
The post-mortem macroscopic and histological examination did not
identify a speciﬁc cause of death in 6 (11.8%) patients. Structural
abnormalities of the heart were identiﬁed in 5 of them, i.e., extensive
coronary arteriosclerosis in 3, dystrophic myocardial changes and
chronic pericarditis in one patient each (Table 3). The patients with
coronary atherosclerosis had no evidence of coronary thrombosis or
myocardial necrosis. The patient with myocardial dystrophy had
ﬁbrofatty replacement, similar to ﬁndings reported in cases of sudden
death produced by arrhythmogenic cardiomyopathy (Basso et al.,
2009), but no pre-mortem evidence of ventricular rhythm disturbance.
No additional virological, toxicological or biochemical studies were
performed.

3.2. Chronological distribution of sudden and unexpected death
The 5-year intervals with the lowest and highest rates of sudden and
unexpected death were 1999–2003 (0.569%) and 2004–2008 (1.085%),
respectively (Fig. 1).
3.3. Comparison of patients who died of myocardial infarction with the
other patients
Patients who died of myocardial infarction (n = 27) and those who
died of another cause (n = 24) were similar with regard to age, gender,
duration of illness, length of stay, psychotropic treatment during their
last admission (Table 1) and past medical history.
A majority of patients in both groups were cigarette smokers (63.0%
vs 66.7%, p = 0.78). The groups with and without myocardial infarction
had similar body mass index (25.0 ± 3.3 vs. 25.9 ± 4.5 kg/m2, p = 0.40)
and proportion of patients with fasting glucose levels ≥ 100 mg/day
(18.5% vs. 16.7%, p = 0.86). Low-density lipoprotein cholesterol levels
were not assessed.
4. Discussion

Table 2
Causes of sudden, unexpected death in schizophrenia inpatients who had a post-mortem
examination.
Cause of death

N (%)

95% conﬁdence interval

Cardiovascular disorders
Myocardial infarction
Myocarditis
Dilated cardiomyopathy
Hemopericardium
Respiratory disorders
Pneumonia
Airway obstruction
Pulmonary embolus
Neurological disorders
Hemorrhagic stroke
Brain tumor
Unexplained

32 (62.8%)
27 (52.9%)
3 (5.9%)
1 (2.0%)
1 (2.0%)
11 (21.6%)
6 (11.8%)
4 (7.8%)
1 (2.0%)
2 (3.9%)
1 (2.0%)
1 (2.0%)
6 (11.8%)

49.5–76.0%
39.2–66.6%
0–12.3%
0–5.8%
0–5.8%
10.3–32.9%
2.9–20.6%
0.5–15.2%
0–5.8%
0–9.2%
0–5.8%
0–5.8%
2.9–20.6%

In this study, we used autopsy ﬁndings to determine the cause of
sudden death in a cohort of 7189 patients admitted for the treatment
of schizophrenia to a free standing teaching psychiatric hospital over a
25-year period (1989–2013). Medical record review identiﬁed 57
(0.79%) patients who died suddenly and unexpectedly during the hospital stay. Autopsies were performed in 51 patients. The post-mortem
examinations indicated that 27 (52.9%) patients had myocardial infarction, 6 (11.8%) pneumonia, 4 (7.8%) airway obstruction, 3 (5.9%) myocarditis, and 1 (2.0%) each dilated cardiomyopathy, hemopericardium,
pulmonary embolus, hemorrhagic stroke and brain tumor. The sudden
death remained unexplained in 6 (11.8%) patients, 3 of whom had
evidence of coronary arteriosclerosis on autopsy. Patients with and without myocardial infarction were similar with regard to age, gender,
smoking, body mass index and psychotropic drug therapy. The rate of
myocardial infarction identiﬁed in this study is greater than that in
community samples (Kannel and Thomas, 1982; Waller et al., 1992)
and, if conﬁrmed in larges samples of patients with schizophrenia, may
represent a speciﬁc vulnerability of patients with this psychotic disorder.
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Table 3
Demographic features and autopsy ﬁndings in schizophrenia patients with unexplained sudden death.
Patient #

Age (years)

Gender

Body mass index

Smoker

Length of stay (days)

Autopsy ﬁndings

1
2
3
4
5
6

32
49
60
66
58
66

Male
Male
Male
Male
Female
Female

29.0
20.1
27.3
32.7
21.1
25.5

Yes
Yes
Yes
Yes
Yes
No

11
6
10
6
2
4

Interstitial pulmonary ﬁbrosis
Coronary arteriosclerosis
Myocardial dystrophy
Coronary arteriosclerosis
Coronary arteriosclerosis
Chronic pericarditis

The data are limited by the lack of toxicological evaluation of cases
without a clear cause of death, incomplete pre-mortem assessments of
risk factors for coronary artery disease, and absence of information
regarding the prevalence and etiology of sudden death in the community from which the psychiatric hospital receives its patients. Nevertheless, this is the ﬁrst study in which all sudden deaths in patients with
schizophrenia have been witnessed and an autopsy was carried out
without delay in a near-totality (89.5%) of cases.
The autopsy ﬁndings support the hypothesis that the causes of sudden
death in schizophrenia are not different than in the community-dwelling
populations (Thomas et al., 1988; Bowker et al., 2003; tavora et al., 2008;
Adabag et al., 2010; Downes et al., 2010) and patients admitted to general
hospitals (Heriot et al., 2010; Nichols and Chew, 2012) without severe
mental illness, in whom unexpected deaths are primarily due to coronary
artery disease that has produced a myocardial infarction. Coronary artery
disease is highly prevalent as a cause of sudden death (42%) even in
subjects aged 30–40 years old (Shen et al., 1995). Advances in genetic
testing aimed at discovering mutations associated with the long QT
syndrome have not changed the etiological hierarchy of sudden death,
as demonstrated by a recent study of 71 patients aged 25–60 who died
suddenly in Minneapolis (Adabag et al., 2010). Acute coronary lesions
were found in 27% of patients and previous silent myocardial infarction
was discovered in 34% of cases, while only 5 subjects (7%) had possibly
deleterious mutations of the ion channel genes.
The data generated by the autopsies in this cohort of patients with
schizophrenia expand the observations previously reported by us on
100 consecutive sudden deaths (18% with autopsy) in psychiatric
patients in a New York psychiatric institution (Manu et al., 2011).
Using structured, multidisciplinary root cause analyses, the cause of
death was identiﬁed in 48 cases (48.0%). Fifteen of those (31.3%) had
evidence of an acute coronary syndrome, while the unexplained cases
were predicted by the presence of diabetes and dyslipidemia, i.e., the
main risk factors for coronary artery disease (Manu et al., 2011). The
utilization of antipsychotic drugs was similar in the explained and unexplained groups, a ﬁnding echoed by the ﬁnding of similar chlorpromazine equivalent dosages of antipsychotics administered during the last
day of life to patients with and without myocardial infarction presented
in our current report. Likewise, the other causes of death discovered at
autopsy in this study were not different from those frequently reported
in our previous survey of psychiatric patients (Manu et al., 2011), in
which we have found a similar prevalence of myocarditis, upper airway
obstruction, pneumonia, pulmonary embolization and hemorrhagic

strokes. The one case of sudden death caused by rapidly expanding
brain tumor is unusual and the proposed mechanism of death
includes herniation due to mass effect, acute hemorrhage and seizures
(Vougiouklakis et al., 2006). Taken together, the data do not support a
construct implying that an antipsychotic-related arrhythmia is the
primary event responsible for a signiﬁcant proportion of sudden deaths
in patients with schizophrenia receiving antipsychotic drugs.
The presence of upper airway obstruction with undigested food
(choking) among the causes of death in this group of schizophrenia
patients reﬂects the high risk of dysphagia in patients with severe
mental illness. In a 400-bed Massachusetts hospital 4 patients died in
1 year from asphyxia. Prospective studies have identiﬁed bradykinetic
dysphagia secondary to neuroleptic-induced extrapyramidal syndrome
(Bazemore et al., 1991) and fast eating syndrome (Fioritti et al., 1997) as
the most common causes of life-threatening choking episodes. The risk
of deep venous thrombosis, leading to pulmonary embolism, is also
increased in patients treated with antipsychotic drugs (Shulman et al.,
2013).
Our ﬁndings suggest that a substantial decrease in the prevalence of
sudden death in schizophrenia can be obtained only through programs
aimed at the primary prevention of coronary artery disease and secondary prevention of myocardial infarction. In the Framingham Heart
Study, from 1950 to 1999, such programs have proven their effectiveness
among individuals without psychotic disorders by decreasing the risks of
sudden death and non-sudden mortality related to coronary artery
disease by 49% and 64%, respectively (Fox et al., 2004). Reductions of
this magnitude will require not only early detection and treatment of
coronary and diabetogenic risk factors in psychiatric settings, but also
parity in access and quality of medical care for patients with schizophrenia. In order to achieve these important goals that have been highlighted
for at least a decade now, provider, patient and system level barriers must
be identiﬁed and addressed (De Hert et al., 2011b).
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